Unlock Premium Data: Up to 50% Off InvestingProCLAIM SALE

Li Ka-shing-backed Well Health to buy CRH Medical for nearly $300 million

Published 2021-02-08, 11:38 a/m
© Reuters.
CRH
-

(Reuters) - Canadian digital healthcare company Well Health Technologies Corp said on Monday it would buy CRH (LON:CRH) Medical Corp for $292.7 million to expand into the United States, in a deal partly funded by its billionaire investor Li Ka-shing.

The move comes days after a unit of the Hong Kong tycoon's CK Group agreed to buy two wind farms in British Columbia, marking its first purchase of a Canadian renewables project.

CRH Medical shareholders will get $4 per share in cash, representing a premium of about 83% to the company's shares' closing price on Friday.

U.S.-listed shares of CRH Medical were trading 80% higher at $3.94, while its Canada-listed shares were at C$5.02.

Well Health said the deal would be funded through a credit facility and cash on hand, with the company raising C$295.5 million ($231.75 million) through an equity offering to a group of investors that includes Li.

Well Health did not disclose details on Li's stake in the company after the deal. Its shares, listed on Toronto Stock Exchange, rose 18% to C$9.46.

CRH Medical provides gastroenterologists in the United States with products and services for the treatment of gastrointestinal diseases, including anesthesia services at 69 ambulatory surgical centers in 13 states.

($1 = 1.2751 Canadian dollars)

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.